Star Health & Allied Insurance – Agents Galore, Claims Drama, and Jhunjhunwala’s Legacy
1. At a Glance
Star Health is India’s first standalone health insurer and still the big boss of retail health with 31% market share. They’ve got more agents than some states have voters – 7.18 lakh spread across 887 branches. Yet, even with ₹16,500 Cr sales in FY25, PAT was a modest ₹589 Cr, giving it a P/E of ~44. That’s like paying fine-dining rates for a thali – you’ll enjoy it, but you’ll also grumble.
2. Introduction
Health insurance is one of those things you love to hate – like gym memberships or income tax. You complain, but you keep paying. Star Health cracked the code early by focusing on retail health insurance instead of chasing corporates. The bet worked: 91% of revenue is retail, renewals run at a sticky 93%, and most policies are in the sweet spot of ₹5 lakh sum insured.
The distribution story is insane. A million+ doctors in India? No, but Star has 718,000 insurance agents pitching cancer, diabetes, and “red carpet” senior citizen policies to you and your uncle. They also tied up with 61 banks, NBFCs, and even fintechs like PhonePe and Paytm to hawk policies at checkout.
Yet, the business model isn’t all roses. Insurance margins are wafer-thin, regulators keep slapping penalties (hello ₹195 Cr GST demand, hello IRDAI fines), and underwriting health claims is like playing gully cricket blindfolded – you never know which ball will break your window.
3. Business Model – WTF Do They Even Do?
Star Health makes money from premiums collected minus claims paid minus expenses. It’s basically a math problem disguised as a social service.
Products: Diabetes Safe, Cancer Care, Cardiac Care, Women Care, Young Star, Senior Citizens Red Carpet – basically, a menu card of diseases.
Channels:
80% Individual agents (your neighbourhood uncle with forms).
8% Bancassurance (banks pushing policies).
7% Digital (finally).
5% Corporate.
Hospital Network: 14,340+ tie-ups = you can get cashless in Tier-1 to Tier-3 cities, though approvals sometimes take longer than railway refunds.
Revenue Mix FY24: Retail health 91%, group health 7%, everything else (PA/OMP/DMP) 2%.
Essentially, they sell policies one by one, renew them at high rates, and hope claims don’t exceed collections. Simple? Yes. Predictable? Not really.
4. Financials Overview
Metric
Latest Qtr (Jun’25)
YoY Qtr (Jun’24)
Prev Qtr (Mar’25)
YoY %
QoQ %
Revenue
₹4,233 Cr
₹3,816 Cr
₹4,081 Cr
+10.9%
+3.7%
EBITDA
₹351 Cr
₹425 Cr
–₹7 Cr
–17%
Turned
PAT
₹263 Cr
₹319 Cr
₹1 Cr
–17.7%
Huge
EPS (₹)
4.5
5.4
0.01
–17%
Huge
Annualised EPS = ~₹18 → P/E ~24x on forward basis. Current P/E = ~44x on trailing basis.
Commentary: From loss in Mar’25 to ₹263 Cr profit in Jun’25. Star is behaving like a T20 batsman – duck one game, fifty in the next.
5. Valuation – Fair Value Range Only
Method 1: P/E
Annualised EPS ~₹18
Assign 20–30x (given growth + volatility).
Range: ₹360 – ₹540
Method 2: EV/EBITDA
FY25 EBITDA ~₹776 Cr, EV ~₹25,688 Cr
EV/EBITDA ~33x. Industry average ~25x.
Fair EV ~₹19,000–₹23,000 Cr → Per share ₹330 – ₹410
Method 3: Price-to-Sales
Sales ₹16,500 Cr, P/S ~1.6x
Fair 1.2–1.6x → ₹330 – ₹440
👉 Overall Fair Value Range: ₹330 – ₹500
Disclaimer: Educational only. Not investment advice.
6. What’s Cooking – News, Triggers, Drama
Penalties Party: IRDAI fined Star ₹3.39 Cr for cyber security lapses. GST demand notices of ₹195 Cr and multiple smaller penalties keep
